Oncolytics Biotech Inc. (ONCY)

[Truthbythought]

Ok I am stimulated. Everyone is getting so excited. So lets look at the numbers they are trying to beat. In the 2002 study with the arm that treated with paclitaxel and carboplatin the treatment showed 34% survival. So that is our control. Unfortunately it had a much larger number of patients, but lets translate that into our study numbers

34% =12 patients 1 year survival with just chemo
53% = 19 patients 1 year survival with chemo and Reo

Difference of 7 people living living 3-4 months longer than the median survival on just the chemo- which was 8-9 months.

So tell me honestly. Is this data everyone is ready to hang their hats on? Just seems like a far reach from anything conclusive. Just a word of caution. I have nothing invested in ONCY and everything tied up in another cancer stock which I will not mention here. I just would not feel comfortable with a big play based on this. However enjoy the ride everyone. But you will need a lot more data before this thing really climbs methinks.

Not trying to get anyone down, just be cautious. Lots of questions still need to be answered here. Its one of the big troubles with combo drugs. How in a small study can you be sure you are helping or just experiencing a statistical bounce in your favor that would have occurred without your treatment.

CLSN anyone....